Literature DB >> 18717194

[Endovascular treatment for dural arteriovenous fistula].

Shigeru Miyachi1.   

Abstract

Intracranial dural arteriovenous fistulas (DAVFs) are acquired abnormal epidural arteriovenous shunts, particularly at the sinus wall. Most of the DAVFs are associated with progressive sinus occlusion. They are located in the cavernous sinus, lateral (transverse-sigmoid) sinus, superior-sagittal sinus, anterior condylar confluence, tentorial sinus, craniocervical junction, and anterior skull base (ethmoidal sinus). The treatment strategy differs based on the etiology and drainage pattern of DAVFs. The most effective treatment for DAVFs at the sinus wall is transvenous embolization (TVE) with coils. The target coil packing is effective if the sinus point is identified. Certain cases that are difficult to approach transvenously are treated with transarterial embolization (TAE) by using liquid materials like such glue. In particular cases with sinus occlusive lesion sinus reconstruction with sinoplasty is effective. The cases with failed or impossible endovascular approach should be treated with surgical interruption of shunts or by radiosurgery. The most frequent complication of TAE is brain and nerve ischemia due to the overembolization or migration, and that in TVE is the bleeding due to obstruction of the drainage route and nerve compression due to overpacking of coils.

Entities:  

Mesh:

Year:  2008        PMID: 18717194

Source DB:  PubMed          Journal:  Brain Nerve        ISSN: 1881-6096


  2 in total

1.  Mechanism of the formation of dural arteriovenous fistula: the role of the emissary vein.

Authors:  E S Miyachi; T Izumi; N Matsubara; T Naito; K Haraguchi; T Wakabayashi
Journal:  Interv Neuroradiol       Date:  2011-06-20       Impact factor: 1.610

2.  A Case Series of Ethmoidal Dural Arteriovenous Fistulas Treated by Endovascular Embolization with Onyx.

Authors:  Hoang Duc Ha; Nguyen Minh Duc; Januel Anne Christine; Cognard Christophe
Journal:  Med Arch       Date:  2020-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.